Skip to content

PoRI Clinical Trial

Randomized Clinical Trial of (PoRI) Post-Stroke Hand Rehabilitation Device

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07407023
Enrollment
12
Registered
2026-02-12
Start date
2026-03-23
Completion date
2027-09-01
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Stroke, Post Stroke Hand Rehabilitation

Keywords

sensorimotor hand dysfunction

Brief summary

This randomized clinical trial compares the Portable Rehabilitation Interface (PoRI) device for rehabilitation of hand motor function in post-stroke patients with conventional hand therapy.

Interventions

DEVICEPortable Rehabilitation Interface (PoRI)

Handheld device known as the Portable Rehabilitation Interface (PoRI) that moves the hand of patients with sensorimotor hand dysfunction

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study population only includes patients who present for follow up management of sensorimotor hand dysfunction (muscle strength less than or equal to 3/5) at the Yale New Haven Hospital's Physical Medicine & Rehabilitation (PM&R) department's Inpatient Rehabilitation Unit.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Between 2 days and a maximum of 2 months have passed since the stroke event * 0-3/5 muscle strength * Participants with paralysis or sensorimotor function problems of the fingers of one or both hands. * Participants must be able to fit their hand comfortably into the device.

Exclusion criteria

* Less than 2 days or greater than 2 months have passed since the stroke event * 4-5/5 muscle strength * Vulnerable populations. * Inability of fingers and wrist to stretch to neutral during passive range of motion

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment (FMA) scoreBaseline and Week 2-3Fugl-Meyer Assessment (FMA) score to assess function with a total score of 100 points. Higher scores mean better recovery, with 0-50 indicating severe impairment and 95-100 showing minimal impairment in motor function, guiding rehabilitation progress.
Box-and-Block Tests (BBT) scoreBaseline and Week 2-3A Box-and-Block Test (BBT) score is the total number of small blocks a person moves from one section of a divided box to another within 60 seconds. More blocks moved equals greater dexterity.
Visual Analog Scale (VAS) Pain scoreBaseline and Week 2-3The VAS pain scale is a tool for assessing pain intensity. Participants will be asked to mark a point on a 100 mm horizontal line that represents the intensity of their pain. This line has two endpoints: 0: No pain and 100: Worst possible pain imaginable. The distance from the "0" to the mark is measured in millimeters with the resulting number (0-100) being the VAS pain score
Short Form McGill Pain Questionnaire (sfMPQ) scoreBaseline and Week 2-3The sfMPQ is scored by summing the values of words that best describe a person's pain. The score ranges from 0 (no pain) to 45 (severe pain).
Mean Score Modified Ashworth Scale (MAS)Baseline and Week 2-3MAS used to assess spasticity level with total score range 0-4. Higher scores indicate more rigidity.

Secondary

MeasureTime frameDescription
Device usability and accessibility surveyWeek 2-3Device usability and accessibility will be evaluated through a patient and researcher survey in the PoRi arm..

Countries

United States

Contacts

CONTACTNecolle Morgado-Vega
necolle.morgado-vega@yale.edu203-843-5733
CONTACTGregory Roytman
gregory.roytman@yale.edu815-382-0687
PRINCIPAL_INVESTIGATORNecolle Morgado-Vega

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026